Elsevier

Journal of Autoimmunity

Volume 15, Issue 2, September 2000, Pages 241-247
Journal of Autoimmunity

Review Article
Experimental Thrombosis and Antiphospholipid Antibodies: New Insights

https://doi.org/10.1006/jaut.2000.0420Get rights and content

First page preview

First page preview
Click to open first page preview

References (36)

  • A.N. Clark et al.

    Clinical uses of intravenous immunoglobulin in pregnancy

    Am. J. Obstet. Gynecol.

    (1997)
  • E.N. Harris

    Syndrome of the black swam

    Br. J. Rheumatol.

    (1987)
  • M.H. Rosove et al.

    Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients

    Ann. Intern. Med.

    (1992)
  • M.A. Khamashta et al.

    Immune mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes

    Ann. Rheum. Dis.

    (1988)
  • A.L. Campbell et al.

    Comparison of the effect of anticardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation

    Thromb. Haemost.

    (1995)
  • P. Hasselaar et al.

    Synergistic effect of low doses of tumor necrosis factor and sera from patients with systemic lupus erythematosus on the expansion of procoagulant activity by cultured ECs

    Thromb. Haemost.

    (1989)
  • S.S. Pierangeli et al.

    Inhibition of protein C activation by antiphospholipid antibodies in vitro is dependent on the composition of phospholipid (PL) liposomes used as template

    Arthritis Rheum.

    (1996)
  • R.G. Malia et al.

    Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies

    Br. J. Haematol.

    (1990)
  • E. Marciniak et al.

    Impaired catalytic function of activated protein C; a new in vitro manifestation of lupus anticoagulant

    Blood

    (1989)
  • N. Del Papa et al.

    Relationship between anti-phospholipid and anti-EC antibodies: β2glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules

    Clin. Exp. Rheumatol.

    (1995)
  • A. Cervera et al.

    Anti-endothelial cell antibodies in patients with the antiphospholipid syndrome

    Autoimmunity

    (1991)
  • J.C. Reverter et al.

    Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein S

    Arterioscler. Thromb. Vasc. Biol.

    (1996)
  • R.L. Bachman et al.

    Hypercoagulable states

    Ann. Intern. Med.

    (1993)
  • N. Del Papa et al.

    Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-β2glycoprotein I antibodies react in vitro with andothelial cells through adherent β2glycoprotein I and induce endothelial activation

    Arthritis Rheum.

    (1997)
  • E. Simanov et al.

    Activation of cultured vascular endothelial cells by antiphospholipid antibodies

    J. Clin. Invest.

    (1995)
  • G. Kaplanski et al.

    Increased soluble vascular cell adhesion molecule 2 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis

    Arthritis Rheum.

    (2000)
  • J. George et al.

    Differential effects of anti-β2glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome

    Circulation

    (1998)
  • A.A. Pierangeli et al.

    Anti-phospholipid antibodies from antiphospholipid syndrome patients activate ECs in vitro and in vivo

    Circulation

    (1999)
  • Cited by (0)

    f1

    Correspondence to: Silvia S. Pierangeli, PhD, Department of Microbiology and Immunology, Rm 1236, 720 Westview Dr SW, Atlanta, GA 30310-1495, USA. Fax: 404-752-1644. E-mail:pierans@ [email protected]

    View full text